original ) (raw )Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Theresa Pizarro
Proceedings of the National Academy of Sciences, 2010
View PDFchevron_right
Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation
Luca Pastorelli
Therapeutic advances in gastroenterology, 2011
View PDFchevron_right
Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease
Hyun-woo Ma
Scientific Reports, 2017
View PDFchevron_right
The Role of IL-33 in Gut Mucosal Inflammation
Theresa Pizarro
Mediators of Inflammation, 2013
View PDFchevron_right
IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis
Nhi Phuong
Frontiers in Immunology, 2021
View PDFchevron_right
Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
Heitor S P de Souza
Mediators of Inflammation, 2014
View PDFchevron_right
IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent
Stefanie Vogel
AJP: Gastrointestinal and Liver Physiology, 2013
View PDFchevron_right
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function
David Wu
Inflammatory Bowel Diseases, 2015
View PDFchevron_right
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Jenna Macciochi
View PDFchevron_right
Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa
Rodrigo Quera , María González
BioMed Research International, 2013
View PDFchevron_right
Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis
Lindsay Hosford
Inflammatory bowel diseases, 2015
View PDFchevron_right
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Claudio Heine , Nancy Farfan , Rodrigo Quera
Inflammatory Bowel Diseases, 2010
View PDFchevron_right
Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
Rasmus Goll
Scientific Reports, 2016
View PDFchevron_right
IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis
Kristine Holgersen
Journal of Gastroenterology, 2014
View PDFchevron_right
Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice
Ronald Muhereze
Molecular medicine (Cambridge, Mass.), 2012
View PDFchevron_right
Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice
Theresa Pizarro
Gastroenterology, 2021
View PDFchevron_right
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
Morten Vatn
The American Journal of Pathology, 2010
View PDFchevron_right
Interleukin-34 - a new modulator of human and experimental inflammatory bowel disease
Madeleen Bosma , Sven Almer
Clinical science (London, England : 1979), 2015
View PDFchevron_right
Mediators of Inflammation and Immune Responses in the Human Gastrointestinal Tract
Eduardo Arranz
Mediators of Inflammation, 2013
View PDFchevron_right
Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis
Izet Hozo
Hepato-gastroenterology
View PDFchevron_right
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation
Silvia Melgar
Mucosal Immunology, 2016
View PDFchevron_right
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Theresa Pizarro
Proceedings of the National Academy of Sciences
View PDFchevron_right
The IL-33-ILC2 pathway protects from amebic colitis
Julio Revilla
Mucosal Immunology, 2021
View PDFchevron_right
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
C. Saris , Sebastian Joyce
International Immunology, 2008
View PDFchevron_right
TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function
De'Broski Herbert
European Journal of Immunology, 2011
View PDFchevron_right
IL-33 regulates the IgA-microbiota axis to restrain IL-1α–dependent colitis and tumorigenesis
Rajendra Karki
Journal of Clinical Investigation, 2016
View PDFchevron_right
A key requirement for CD300f in innate immune responses of eosinophils in colitis
M- ITAN
Mucosal Immunology, 2016
View PDFchevron_right